Benzinga · Feb 26, 2026
IN
NYSE · INSP
Inspire Medical Systems, Inc.
Healthcare · Medical - Devices
$68.12
Up+$1.64 (+2.47%)
Updated Sep 11, 2026, 4:49 AM
SID Score
4.4/10
Composite research score
Smart Money
58/100
Neutral
- Market cap
- 4.05B
- P/E ratio
- 76.09
- Dividend yield
- 0.00%
- 52-week range
- $38.91 – $147.03
- Volume
- 1.14M
- Avg. volume
- 1.3M
Price performance
INSP price history
1M range · 20 trading sessions · Daily adjusted prices
INSP closed at $68.12 after 20 trading sessions, up 17.04% for the selected period.
- Last close
- $68.12
- Period change
- +17.04%
- Period low
- $57.10
- Period high
- $68.12
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 10, 2026 | $64.35 | $68.50 | $64.02 | $68.12 | 1.14M |
| Sep 9, 2026 | $62.43 | $67.7229 | $62.009 | $66.48 | 1.2M |
| Sep 8, 2026 | $64.03 | $64.12 | $61.61 | $62.14 | 621.54K |
| Sep 4, 2026 | $61.00 | $63.43 | $60.00 | $63.08 | 425.72K |
| Sep 3, 2026 | $63.70 | $63.755 | $61.65 | $62.14 | 398.86K |
| Sep 2, 2026 | $61.24 | $64.335 | $61.19 | $63.07 | 413.01K |
| Sep 1, 2026 | $63.00 | $63.50 | $61.20 | $61.52 | 351.71K |
| Aug 31, 2026 | $60.43 | $63.01 | $60.235 | $62.99 | 514.99K |
| Aug 28, 2026 | $60.52 | $62.05 | $60.50 | $61.44 | 517.99K |
| Aug 27, 2026 | $62.10 | $62.8018 | $60.50 | $60.82 | 315.78K |
| Aug 26, 2026 | $60.07 | $62.46 | $60.01 | $61.80 | 327.28K |
| Aug 25, 2026 | $61.19 | $61.89 | $60.38 | $61.07 | 524.82K |
| Aug 24, 2026 | $62.08 | $62.70 | $60.79 | $61.47 | 529.86K |
| Aug 21, 2026 | $61.17 | $63.20 | $60.345 | $62.36 | 407.97K |
| Aug 20, 2026 | $60.94 | $62.20 | $58.0009 | $61.27 | 474.86K |
| Aug 19, 2026 | $57.80 | $61.96 | $57.80 | $61.69 | 578.13K |
| Aug 18, 2026 | $57.32 | $58.14 | $57.00 | $57.38 | 656.66K |
| Aug 17, 2026 | $56.40 | $57.23 | $55.44 | $57.22 | 519.68K |
| Aug 14, 2026 | $58.11 | $58.11 | $56.97 | $57.10 | 396.92K |
| Aug 13, 2026 | $57.99 | $58.83 | $57.10 | $58.20 | 485.92K |
Latest INSP news
The latest Smart Investors Daily articles mentioning INSP.
Stock researchCompany · Overview
INSP research
Overview
Company profile and research snapshot.
Company profile
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $139.92
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 4, 2026 | Evercore ISI Group | In-Line | — |
| Aug 4, 2026 | Piper Sandler | Neutral | — |
| Aug 4, 2026 | Baird | Neutral | — |
| Aug 4, 2026 | Oppenheimer | Outperform | — |
| Aug 4, 2026 | Truist Securities | Hold | — |
News briefing
No generated briefing is available yet.
Benzinga · Feb 26, 2026
Inspire Medical Systems shares are trading higher after a KeyBanc note indicated that CMS appears ready to add INSP V Specific C-Codes in April 2026 IOCE update
Benzinga · Feb 26, 2026
Inspire Medical Systems Trading Halted
Fintel · Feb 25, 2026
Inspire Medical Systems (INSP) Price Target Decreased by 27.11% to 95.55
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
